"Defining Success in Organ Transplantation: Where Do We Go From Here?”
February 17- 19, 2022
The stage will be set by looking at current definitions of success from all key stakeholders - federal, insurers, patients, care providers and understanding the implications of having different stakeholders whose perspectives on success do not always align. The program will then delve into potential alternatives definitions of success at the societal and systems levels as well as for patients and caregivers. Tying in the themes from the ASHI meeting that CEOT 2022 immediately follows, each organ and the infectious disease group with specialized tracks will delve into the Yin and Yang of infection and rejection on the spectrum of immunosuppression. The overarching goal is to systematically examine and refine definitions of success for all stakeholders in transplantation to inform and reframe future conversations in organ transplantation.
Who should attend?
For CEoT 2022, AST will make every effort to:
- Emphasize the health and safety of participants, vendors, staff, and other stakeholders.
- Manage the situation with the COVID-19 pandemic as proactively as possible.
- Ensure a meaningful experience for every participant (regardless of virtual or in-person participation).